Tracy Hussell

Has grant

The University of Manchester
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Immunomatrix in Complex Disease (ICD)

Open Date: 2020-10-01

Close Date: 2028-09-30

Grant: Close

Role of STAT1 Cooperative DNA Binding in Interferon Signalling

Open Date: 2013-07-31

Close Date: 2016-07-30

Grant: Close

Innate immune parameters leading to virus-induced secondary bacterial pneumonia and sepsis.

Open Date: 2010-12-01

Close Date: 2013-11-30

Grant: Close

Development of a viral exacerbation model of allergic asthma

Open Date: 2008-06-30

Close Date: 2008-12-31

Grant: Close

Innate priming and the immunopathogenesis of lung co-infections

Open Date: 2005-08-31

Close Date: 2008-11-30

Articles (18)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Airborne fungi are potent inducers of respiratory disease and cause the debilitating conditions severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA). However, the immune cell types and the inflammatory airway environment that defines SAFS and ABPA patients is not extensively characterised. To address this, we recruited SAFS and ABPA patients, asthmatics without evidence of fungal sensitisation and healthy controls (n= 20 individuals per group). Immune cells were isolated from collected sputum and peripheral blood samples and immunophenotyping was performed via flow cytometry. By applying a machine learning approach to our dataset, we identify a critical association between CD4 + T cells, type 2 conventional dendritic cells, eosinophils, proinflammatory factors and severe respiratory disease. These complex immune signatures should be investigated further to improve the diagnostics and treatment of SAFS and ABPA. Graphical abstract

Year:

2025

Collagen deposition in fibroblasts, the primary collagen-producing cells, is regulated by both macrophages and the circadian rhythm, although how these regulatory processes interact with one another is unknown. Here, we reveal that macrophage-fibroblast interaction enhances collagen deposition which requires a functional circadian rhythm. This response is also dependent on macrophage polarisation status, where M0 (naïve) and M1 (pro-inflammatory) macrophages require direct cell-cell contact; whereas M2 (anti-inflammatory) macrophages utilise an additional mechanism through secreted soluble factors that strengthen circadian rhythms and significantly increase collagen deposition in fibroblasts, independent of cell-cell contact. Using mass spectrometry proteomics analysis, we identified PDGFA as a key factor in induction of circadian amplitude in fibroblasts. Crucially, macrophages lacking PDGFA showed diminished ability to modulate fibroblast circadian rhythms and collagen production. Further, in fibroblasts with impaired circadian rhythms, neither macrophages nor macrophage-secreted factors are capable of inducing collagen deposition. These results confirmed that the collagen secretory pathway is also under circadian clock control in lung fibroblasts, and demonstrated that macrophages influence collagen deposition via circadian clock mediated mechanisms. In conclusion, our findings highlight M2-derived PDGFA as a key macrophage-derived factor in extracellular matrix remodelling.

Year:

2025

Year:

2024

Even within a single protein, antibody binding can have beneficial, neutral, or harmful effects during the response to infection. Resolving a polyclonal antibody repertoire across a pathogen’s proteome to specific epitopes may therefore explain much of the heterogeneity in susceptibility to infectious disease. However, the three-dimensional nature of antibody-epitope interactions makes the discovery of non-obvious targets challenging. We implemented a novel computational method and synthetic biology pipeline for identifying epitopes that are functionally important in the SARS-CoV-2 proteome and identified an IgM-dominant response to an exposed Membrane protein epitope which to our knowledge is the strongest correlate of severe disease identified to date (adjusted OR 72.14, 95% CI: 9.71 – 1300.15), stronger even than the exponential association of severe disease with age. We also identify persistence (> 2 years) of this IgM response in individuals with longCOVID, and a correlation with fatigue and depression symptom burden. The repetitive arrangement of this epitope and the pattern of isotype class switching is consistent with this being a previously unrecognized T independent antigen. These findings point to a coronavirus host-pathogen interaction characteristic of severe virus driven immune pathology. This epitope is a promising vaccine and therapeutic target as it is highly conserved through SARS-CoV-2 variant evolution in humans to date and in related coronaviruses (e.g. SARS-CoV), showing far less evolutionary plasticity than targets on the Spike protein. This provides a promising biomarker for longCOVID and a target to complement Spike-directed vaccination which could broaden humoral protection from severe or persistent disease or novel coronavirus spillovers.

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (48)

Susanna Dunachie

Professor at University of Oxford

University of Oxford

UNITED KINGDOM
View details

Iashia Nabi

The University of Manchester

UNITED KINGDOM
View details

Rachel Lennon

The University of Manchester

UNITED KINGDOM
View details

Anna Nicolaou

The University of Manchester

UNITED KINGDOM
View details

Timo Hautala

Professor in microbiology and immunology

University of Oulu

FINLAND
View details

Karl Kadler

The University of Manchester

UNITED KINGDOM
View details

Megan Sutcliffe

The University of Manchester

UNITED KINGDOM
View details

Sofie Eg Jørgensen

Assistant professor

Aarhus University

DENMARK
View details

Patrick Kearns

ECAT/Wellcome Trust Clinical Lecturer

University of Edinburgh

UNITED KINGDOM
View details

Jean-Marc Schwartz

The University of Manchester

UNITED KINGDOM
View details

Tracy Briggs

The University of Manchester

UNITED KINGDOM
View details

Gaia Gestri

University College London

UNITED KINGDOM
View details

John Grainger

The University of Manchester

UNITED KINGDOM
View details

Pilar Rivera-Ortega

Associate Research and Development Director

Manchester University NHS Foundation Trust

UNITED KINGDOM
View details

David Cavanagh

Senior Lecturer

University of Edinburgh

UNITED KINGDOM
View details

Julian Knight

University of Oxford

UNITED KINGDOM
View details

Teresa Lambe

University of Oxford

UNITED KINGDOM
View details

Tomohiko Yamamura

assistant professor

Kobe University

JAPAN
View details

Ben Mulhearn

The University of Manchester

UNITED KINGDOM
View details

Peter Cook

University of Exeter

UNITED KINGDOM
View details

Paul Dark

Professor of Critical Care

The University of Manchester

UNITED KINGDOM
View details

Douglas Dyer

The University of Manchester

UNITED KINGDOM
View details

Karen Piper Hanley

The University of Manchester

UNITED KINGDOM
View details

David Denning

Professor of Infectious Diseases in Global Health

The University of Manchester

UNITED KINGDOM
View details

Joseph Marsh

University of Edinburgh

UNITED KINGDOM
View details

Gabriella Lindergard

Clinical Lecturer in Nursing (NIHR-ICAT)

The University of Manchester

UNITED KINGDOM
View details

Nick Gilbert

Principal Investigator

University of Edinburgh

UNITED KINGDOM
View details

Stephen Carter

Lecturer (Teaching)

University College London

UNITED KINGDOM
View details

Sean Knight

The University of Manchester

UNITED KINGDOM
View details

Angela Simpson

The University of Manchester

UNITED KINGDOM
View details

Philip D. King

University of Michigan Medical School

UNITED STATES
View details

Alexander Mentzer

Principal Investigator / Clinical Research Scientist

University of Oxford

UNITED KINGDOM
View details

Christopher E. M. Griffiths

The University of Manchester

UNITED KINGDOM
View details

Grant Stewart

Professor of Cancer Genetics

University of Birmingham

UNITED KINGDOM
View details

Matthew Hepworth

The University of Manchester

UNITED KINGDOM
View details

Andrew S MacDonald

The University of Manchester

UNITED KINGDOM
View details

Magnus Rattray

The University of Manchester

UNITED KINGDOM
View details

Matthew Guille

Academic, Professor, Professor of Developmental Genetics

University of Portsmouth

UNITED KINGDOM
View details

Joan Chang

Senior Research Fellow

The University of Manchester

UNITED KINGDOM
View details

Qing Jun Meng

The University of Manchester

UNITED KINGDOM
View details

Christine Chew

Academic , NIHR Academic Clinical Lecturer in Paediatrics

University of Bristol

UNITED KINGDOM
View details

Alexander Eckersley

The University of Manchester

UNITED KINGDOM
View details

Nicholas Scott

The University of Manchester

UNITED KINGDOM
View details

Susan Rosser

Professor of Synthetic Biology

University of Edinburgh

UNITED KINGDOM
View details

Stefano Adriano Colombo

The University of Manchester

UNITED KINGDOM
View details

William Gordon Charles Horsnell

Professor

University of Exeter

UNITED KINGDOM
View details

Madhvi Menon

The University of Manchester

UNITED KINGDOM
View details

Laurence Pearmain

The University of Manchester

UNITED KINGDOM
View details